[SCHEDULE 14A (Amendment No. 1) Check the appropriate box: [ ] Preliminary Proxy Statement CHINA BIOLOGIC PRODUCTS, INC. __________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of]
[SCHEDULE 14A (Amendment No. 1) Check the appropriate box: [ ] Preliminary Proxy Statement CHINA BIOLOGIC PRODUCTS, INC. __________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of]
[SCHEDULE 14A (Amendment No. 1) Check the appropriate box: [X] Preliminary Proxy Statement CHINA BIOLOGIC PRODUCTS, INC. __________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities]
[SCHEDULE 14A (Amendment No. 1) Check the appropriate box: [X] Preliminary Proxy Statement CHINA BIOLOGIC PRODUCTS, INC. __________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities]
[SCHEDULE 14A (Amendment No.1) Check the appropriate box: [X] Preliminary Proxy Statement CHINA BIOLOGIC PRODUCTS, INC. __________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): June 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China 86 10 6598 3111 (Former name]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): June 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China 86 10 6598 3111 (Former name]
[SCHEDULE 14A [ ] Preliminary Proxy Statement [ ] [ ] Definitive Proxy Statement [ X ] Definitive Additional Materials [ ] Soliciting Material under Rule 14a-12 CHINA BIOLOGIC PRODUCTS, INC. Payment of Filing Fee (Check the appropriate box): [ ] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title]
[EXECUTION COPY SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement (1) WP X WPP X, Purchasers Purchaser (2) IDG Fund IDG Investors Sellers Seller Parties Party Sellers and Purchasers are collectively referred to herein as the WHEREAS: 1. Company China Biologic Products, Inc. (the 2. Shares The Company is listed on NASDAQ. As of April 23, 2012, a] []
[EXECUTION COPY SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement (1) WP X WPP X, Purchasers Purchaser (2) IDG Fund IDG Investors Sellers Seller Parties Party Sellers and Purchasers are collectively referred to herein as the WHEREAS: 1. Company China Biologic Products, Inc. (the 2. Shares The Company is listed on NASDAQ. As of April 23, 2012, a] []
